Diacarta L.L.C.
- UEI
- Q25LJZJK2BR1
- CAGE
- 4U8W2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- diacarta.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| FGF-p to treat post-irradiation GI syndrome | National Institutes of Health | $594,739 |
Quick answers
Is Diacarta L.L.C. registered in SAM.gov?
Diacarta L.L.C.'s SAM.gov registration expired on October 13, 2018.
What is Diacarta L.L.C.'s most recent federal award?
Diacarta L.L.C.'s most recent federal contract award is Topic 345 - sbir phase II: radtox - measuring radiation toxicity using circulating DNA (75N91018C00036), from National Cancer Institute (NIH), on September 17, 2018.
On GovTribe
See Diacarta L.L.C.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors